Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States

(See the editorial commentary by Jain et al, on pages 707–709.) Background. Peramivir, an investigational intravenous neuraminidase inhibitor in Phase 3 trials for hospitalized patients, was made available during the 2009 H1N1 influenza pandemic under the Emergency Investigational New Drug (eIND) re...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hernandez, Jaime E., Adiga, Raghavendra, Armstrong, Robert, Bazan, Jose, Bonilla, Hector, Bradley, John, Dretler, Robin, Ison, Michael G., Mangino, Julie E., Maroushek, Stacene, Shetty, Avinash K., Wald, Anna, Ziebold, Christine, Elder, Jenna, Hollister, Alan S., Sheridan, William
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2011
Assuntos:
Articles and Commentaries
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3049340/
https://ncbi.nlm.nih.gov/pubmed/21367722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cir001
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares